603717 天域生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.311-18.440-52.666-24.726--
总资产报酬率 ROA (%)-0.052-3.310-13.779-9.241--
投入资产回报率 ROIC (%)-0.080-4.988-20.336-13.355--

边际利润分析
销售毛利率 (%)13.16410.833-34.41811.3267.704
营业利润率 (%)0.805-11.188-84.931-34.186-37.710
息税前利润/营业总收入 (%)8.311-9.631-83.382-31.980-31.620
净利润/营业总收入 (%)1.992-10.835-84.404-28.415-34.566

收益指标分析
经营活动净收益/利润总额(%)-233.60853.41262.3899.50440.938
价值变动净收益/利润总额(%)20.3580.2456.237-0.582-7.412
营业外收支净额/利润总额(%)67.961-2.8831.583-1.968-2.087

偿债能力分析
流动比率 (X)1.2191.0791.3141.693--
速动比率 (X)1.0130.9131.1861.481--
资产负债率 (%)76.40677.96274.50559.130--
带息债务/全部投入资本 (%)58.48255.96850.30942.066--
股东权益/带息债务 (%)46.00444.09758.272112.619--
股东权益/负债合计 (%)22.63420.69626.48054.637--
利息保障倍数 (X)1.434-7.744-28.604-20.685-5.945

营运能力分析
应收账款周转天数 (天)176.086173.209229.198198.5750.000
存货周转天数 (天)128.44196.56279.76774.2630.000